CA-ARISTA-NETWORKS
Arista Networks (NYSE:ANET) today announced another milestone in revolutionizing the broadcast industry with live demonstrations at IBC 2016 (Hall 8 Booth A11) highlighting the migration of legacy broadcast plants to standards based IP. Working with key partners, the demonstrations highlight a seamless and self-paced transition of broadcast operations to a more agile, standards based and cost-efficient media environment enabled with Arista EOS (Extensible Operating System).
IP Broadcast Solutions Highlighted at IBC 2016
The transition to IP for TV Stations and Broadcasters enables new market opportunities and network agility. Arista will showcase the power of standards based interoperability for Professional Media Networks with 20 AIMS (Alliance for IP Media Solutions) partners. The Arista Universal Cloud Network, supporting the latest SMPTE 2059-2 PTP standard, hitless upgrades, and deep buffer switches, is the foundation for even the most demanding media networks. Partner interoperability demonstrations include: Aja, Aperi, Avid Technologies, Cobalt Digital, Coveloz, Embrionix, Evertz, EVS, Grass Valley, Harmonic, Ikegami, Imagine Communications, Lawo, Macnica, NetInsight, Nevion, Riedel, Snell Advanced Media, SuitcaseTV, Tektronix, Utah Scientific, and Vizrt.
Demonstrations include frame accurate switching, leveraging Lawo and Imagine Communications IP Media SDN controllers, enabled by Arista’s EOS Application Programming Interface (API) integration. SDN controllers provide network visibility, bandwidth control and ease of use required for today’s media workflows.
Next Generation Video Distribution
Arista’s Software Driven Cloud Networking platforms deliver high-speed storage and network scalability and throughput necessary for 4K video and evolving higher resolution video standards. Advanced 3D and VFX media projects, requiring low latency, high throughput networks with low transaction completion times, are enabled via Arista EOS and demonstrated with Avid NEXIS™.
For customers looking for next generation digital signage, medical imaging or telemedicine, Arista and ZeeVee will be demonstrating a scalable, flexible, cost effective solution for sending video to any display across a room, enterprise, building, or campus. The Arista and ZeeVee ZyPer solution is perfect for moving content through the production work flow, throughout a stadium or arena, or within an operating theater, ensuring a faultless, immersive, high and ultra high definition viewing experience.
Partner Quotes
“Today's media industry is pushing the limits with Ultra HD/4k production and multiplatform story creation," said Alan Hoff, vice president, Market Solutions, Avid . "The combination of the Avid NEXIS family with Arista cloud networking platforms, deliver an ideal environment for scalable video post production environments.”
“Working with Arista and their incredibly robust and scalable, high density switches provides us with a unique opportunity to show off the full capabilities of the ZyPer platform to IBC attendees. Their switches provide demanding customers with the capability to leverage a single network for providing a fully integrated IP infrastructure where video and data can co-exist seamlessly,” said Rob Muddiman, EMEA Sales Director for ZeeVee .
About Arista Networks
Arista Networks was founded to pioneer and deliver software-driven cloud networking solutions for large data center storage and computing environments. Arista's award-winning platforms, ranging in Ethernet speeds from 10 to 100 gigabits per second, redefine scalability, agility and resilience. Arista has shipped more than five million cloud networking ports worldwide with CloudVision and EOS, an advanced network operating system. Committed to open standards, Arista is a founding member of the 25/50GbE consortium. Arista Networks products are available worldwide directly and through partners.
ARISTA, EOS, CloudVision, Spline, NetDB, and FlexRoute are among the registered and unregistered trademarks of Arista Networks, Inc. in jurisdictions around the world. Other company names or product names may be trademarks of their respective owners. Additional information and resources can be found at www.arista.com . This press release contains forward-looking statements including, but not limited to, statements regarding the benefits and best practices utilized in the design and implementation of Arista's Cloud Networking Portfolio and the enablement of opex savings and higher service level agreements. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward looking statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the forward looking statements including: our limited operating history and experience with developing and releasing new products; product, support or service quality problems; rapidly evolving changes in technology, customer requirements and industry standards as well as other risks stated in our filings with the SEC available on Arista's website at www.arista.com and the SEC's website at www.sec.gov . Arista disclaims any obligation to publicly update or revise any forward-looking statement to reflect events that occur or circumstances that exist after the date on which they were made.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160908006736/en/
Contact:
Arista Networks
Media Contact
Amanda Jaramillo,
408-547-5798
Corporate Communications
amanda@arista.com
or
Investor
Contact
Chuck Elliott, 408-547-5549
Product and Investor
Advocacy
chuck@arista.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
30 Peer-Reviewed Studies Highlight Statistically Significant Health Benefits of Almased16.7.2025 09:15:00 CEST | Press release
Two recent, peer-reviewed clinical studies have found that Almased, a high-protein, low-glycemic meal replacement, delivers significant health benefits ranging from weight loss and improved metabolic health to anti-aging effects and enhanced quality of life. Both reviews synthesize 30 peer-reviewed clinical studies across three decades of scientific research, confirming that Almased is effective and safe for weight reduction, preservation of lean muscle mass, and cardiovascular health. The 2025 review in the American Journal of Biomedical Science & Research highlighted Almased’s efficacy and safety for wide groups of people including individuals seeking weight loss, those with metabolic syndrome or fatty liver, older adults needing to preserve muscle mass, and athletes or healthy-weight individuals who require additional high-quality protein. This review also discusses how Almased’s patented fermentation process produces over 80 bioactive peptides, including 2 times the average daily i
The Future of Connectivity Starts Here: Network X Returns to Paris October 14 - 1616.7.2025 09:00:00 CEST | Press release
Show Reconvenes at Paris Expo Porte de Versailles with Global Representation of Industry Leaders and Telco Experts Network X 2025 - the only event that brings the fixed and mobile markets together - returns to Paris Expo Porte de Versailles October 14 - 16. Built for telecom's top players, this annual show drives business model innovation and monetisation of next-generation fixed, mobile, satellite and transport networks through AI and cloud. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716595903/en/ Speaker on Headliners Stage at Network X 2024 New to Network X in 2025 are specialty events designed to deliver expert insights on trending topics including Data Center World and two Expo Stages for Fixed-Line and Mobile. More than 5,500 telco network infrastructure professionals will gather alongside 1,500 telcos to learn from six program tracks highlighting the latest advancements in Fibre, Wi-Fi Networks and Services, IP
Skechers AERO Series Opens New Chapter of Technical Running Innovation16.7.2025 09:00:00 CEST | Press release
New Collection Features an Evolution in Design that Cuts Through the Wind for That Aerodynamic Feel on Every Run Skechers Performance opens a new chapter of running innovation with the arrival of the Skechers AERO series. Named for the aerodynamic feel of the design, Skechers AERO represents the latest evolution of technical running shoes from the brand. The collection is engineered to deliver an exhilarating blend of speed, style and comfort to help runners cut through the wind and push beyond their personal bests while logging miles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250716754749/en/ Introducing the Skechers AERO Series of technical running shoes: Skechers AERO Burst, Skechers AERO Spark, and Skechers AERO Tempo (L-R). “Recently launched in North America and Asia, the AERO Series leverages innovative technologies to elevate our signature comfort that’s now available to runners in Europe,” said Ben Stewart, Vic
4Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis16.7.2025 07:00:00 CEST | Press release
- First patient enrolled in INFLAM MOTION, a global randomized Phase 2a trial including 129 knee osteoarthritis patients - 4P004 to be evaluated over 3 months for dual efficacy: symptom relief and synovial health improvement via contrast-enhanced MRI - Topline results expected in the second half of 2026 4Moving Biotech (4MB), a spin-off of 4P-Pharma dedicated to developing first-in-class treatments that modify the natural course of knee osteoarthritis (OA), today announced that the first patient has been enrolled in Phase 2a clinical trial, INFLAM MOTION. The study will evaluate 4P004, an intra-articular GLP-1 analog, as a potential first-in-class therapeutic candidate for knee osteoarthritis. INFLAM MOTION is a multicenter, randomized, double-blind, placebo-controlled Phase 2a trial planned to be conducted across Europe, the United States, and Canada. A total of 129 patients worldwide diagnosed with knee OA will be enrolled to evaluate, for the first time in humans, the efficacy of 4P
Belkin Achieves Qi2.2 Certification for Its Upcoming Products, Unlocking the Future of 25W Wireless Charging15.7.2025 19:06:00 CEST | Press release
With Qi2.2 certification, Belkin reinforces its commitment to quality, safety, and performance for the next generation of wireless charging Belkin, a leading consumer electronics brand for over 40 years, today announced it has received official Qi2.2 certification from the Wireless Power Consortium (WPC) for its upcoming products. As one of the first accessory brands to deliver Qi2.2-certified devices, Belkin is helping bring the next generation of wireless charging to market – enabling faster wireless charging speeds, broader compatibility, and improved performance for consumers. Belkin’s close partnership with the WPC since 2015 has been instrumental in bringing these advancements to consumers. As an early adopter and long-time contributor to WPC standards, Belkin was selected as one of a small group of trusted manufacturers to test and certify Qi2.2 products ahead of the broader industry rollout. All Belkin products undergo rigorous safety, quality, and performance testing. The comp
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom